University Of Oxford And ReciBioPharm Expand Strategic Collaboration In Fight Against Malaria
Expands the collaboration to manufacture two malaria vaccine candidates (R78C and RH5.1) for Phase 1/2 clinical trials. Delivers the sixth malaria vaccine candidate for the University of Oxford. Provides drug substance, drug product and large-scale …